Evidence map›Paper›PMID 25393952›Full record

Trial reportPloS one2014

Inactivation of human salivary glutathione transferase P1-1 by hypothiocyanite: a post-translational control system in search of a role.

Raffaele Fabrini, Alessio Bocedi, Serena Camerini, Marco Fusetti, Fabrizio Ottaviani, Francesco M Passali, Davide Topazio, Federica Iavarone, Irene Francia, Massimo Castagnola and 1 more

Open access · goldAbstract readClinical Trial
In one paragraph

Trial report in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. The cysteine proteome.Free radical biology & medicine · 2015
    Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Raffaele FabriniDepartment of Chemical Sciences and Technologies, University of Rome "Tor Vergata", 00133 Rome, Italy.
Alessio BocediDepartment of Chemical Sciences and Technologies, University of Rome "Tor Vergata", 00133 Rome, Italy.
Serena CameriniDepartment of Cell Biology and Neurosciences, Istituto Superiore di Sanità, 00161 Rome, Italy.
Marco FusettiDepartment of Applied Clinical Sciences, University of L'Aquila, 67100 L'Aquila, Italy.
Fabrizio OttavianiDepartment of Clinical Sciences and Translational Medicine, University of Rome "Tor Vergata", 00133 Rome, Italy.
Francesco M PassaliDepartment of Clinical Sciences and Translational Medicine, University of Rome "Tor Vergata", 00133 Rome, Italy.
Davide TopazioDepartment of Clinical Sciences and Translational Medicine, University of Rome "Tor Vergata", 00133 Rome, Italy.
Federica IavaroneInstitute of Biochemistry and Clinical Biochemistry, Catholic University and/or Institute for Molecular Recognition, National Research Council, 00168 Rome, Italy.
Irene FranciaDepartment of Chemical Sciences and Technologies, University of Rome "Tor Vergata", 00133 Rome, Italy.
Massimo CastagnolaInstitute of Biochemistry and Clinical Biochemistry, Catholic University and/or Institute for Molecular Recognition, National Research Council, 00168 Rome, Italy.
Giorgio RicciDepartment of Chemical Sciences and Technologies, University of Rome "Tor Vergata", 00133 Rome, Italy.
University of Rome Tor Vergata · ITNational Research Council · ITIstituto Superiore di Sanità · ITUniversity of L'Aquila · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Glutathione transferases (GSTs) are a superfamily of detoxifying enzymes over-expressed in tumor tissues and tentatively proposed as biomarkers for localizing and monitoring injury of specific tissues. Only scarce and contradictory reports exist about the presence and the level of these enzymes in human saliva. This study shows that GSTP1-1 is the most abundant salivary GST isoenzyme, mainly coming from salivary glands. Surprisingly, its activity is completely obscured by the presence of a strong oxidizing agent in saliva that causes a fast and complete, but reversible, inactivation. Although salivary α-defensins are also able to inhibit the enzyme causing a peculiar half-site inactivation, a number of approaches (mass spectrometry, site directed mutagenesis, chromatographic and spectrophotometric data) indicated that hypothiocyanite is the main salivary inhibitor of GSTP1-1. Cys47 and Cys101, the most reactive sulfhydryls of GSTP1-1, are mainly involved in a redox interaction which leads to the formation of an intra-chain disulfide bridge. A reactivation procedure has been optimized and used to quantify GSTP1-1 in saliva of 30 healthy subjects with results of 42±4 mU/mg-protein. The present study represents a first indication that salivary GSTP1-1 may have a different and hitherto unknown function. In addition it fulfills the basis for future investigations finalized to check the salivary GSTP1-1 as a diagnostic biomarker for diseases.

Indexed as

AdultAgedAnti-Infective AgentsBiomarkersEnzyme InhibitorsFemaleGlutathione S-Transferase piHumansMaleMiddle AgedSalivaSalivary Proteins and PeptidesThiocyanatesAnti-Infective AgentsBiomarkersEnzyme InhibitorsGlutathione S-Transferase piGSTP1 protein, humanhypothiocyanite ionSalivary Proteins and PeptidesThiocyanates

Identifiers

PMID25393952
PMCPMC4231102
OpenAlexW2116846717

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.